1. FRI0566 Teriparatide and alendronate improved bone loss and hyperalgesia in a mouse model of osteoporosis. (15th June 2017) Authors: Nagao, N; Wakabayashi, H; Kato, S; Miyamura, G; Naito, Y; Sudo, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes. Issue 10 (7th July 2010) Authors: Nakamura, M; Yabe, I; Sudo, A; Hosoki, K; Yaguchi, H; Saitoh, S; Sasaki, H Journal: Journal of medical genetics Issue: Volume 47:Issue 10(2010) Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Significance of soluble PD-L1 for malignant tumors. Issue 4 (2019) Authors: Asanuma, K; Nakamura, T; Hagi, T; Kita, K; Sudo, A Journal: Journal of translational science Issue: Volume 5:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Successful treatment with cyclosporine and anti-tumour necrosis factor agent for deficiency of adenosine deaminase-2. (4th May 2021) Authors: Keino, D; Kondoh, K; Kim, Y; Sudo, A; Ohyama, R; Morimoto, M; Nihira, H; Izawa, K; Iwaki-Egawa, S; Mori, T; Kinoshita, A Journal: Scandinavian journal of rheumatology Issue: Volume 50:Number 3(2021) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗